BETAXOLOL HYDROCHLORIDE - leitarniðurstöður

Írland - enska - HPRA (Health Products Regulatory Authority)

betoptic

novartis ireland limited - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - betaxolol

Írland - enska - HPRA (Health Products Regulatory Authority)

betoptic suspension single dose

novartis ireland limited - betaxolol hydrochloride - eye drops suspension - 0.25 %w/v - betaxolol

Kanada - enska - Health Canada

betoptic/pilo suspension

alcon canada inc - betaxolol (betaxolol hydrochloride); pilocarpine hydrochloride - suspension - 0.25%; 1.75% - betaxolol (betaxolol hydrochloride) 0.25%; pilocarpine hydrochloride 1.75% - beta-adrenergic agents

Bandaríkin - enska - NLM (National Library of Medicine)

pilocarpine hydrochloride solution/ drops

sandoz inc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - pilocarpine hydrochloride ophthalmic solution is indicated for the: . . . . none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Bandaríkin - enska - NLM (National Library of Medicine)

pilocarpine hydrochloride- pilocarpine hydrochloride ophthalmic solution solution/ drops

somerset therapeutics, llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride ophthalmic solution, is indicated for the: none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. pilocarpine hydrochloride ophthalmic solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when pilocarpine hydrochloride ophthalmic solution is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

Írland - enska - HPRA (Health Products Regulatory Authority)

betoptic 0.5 base %w/v eye drops solution

ltt pharma limited - betaxolol hydrochloride - eye drops solution - 0.5 base %w/v

Írland - enska - HPRA (Health Products Regulatory Authority)

betoptic 0.5 %w/v eye drops solution

alcon laboratories (uk) ltd - betaxolol hydrochloride - eye drops solution - 0.5 %w/v - beta blocking agents

Írland - enska - HPRA (Health Products Regulatory Authority)

betoptic 0.5% w/v eye drops, solution

pco manufacturing ltd. - betaxolol hydrochloride - eye drops, solution - 0.5% percent weight/volume - beta blocking agents1); betaxolol